Retatrutide 12mg

Retatrutide 12 mg – Triple-Agonist Research Peptide

FOR LABORATORY RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION.

Scientific Background

Retatrutide is a synthetic peptide under investigation for concurrent
agonist activity at GLP-1,
GIP, and
glucagon receptors. Ongoing in-vitro studies examine multi-receptor
signalling and downstream metabolic pathways.

Specification

• Peptide Name: Retatrutide
• Content: 12 mg lyophilized powder (requires reconstitution)
• Purity: ≥ 99 % (HPLC / MS certificate available)
• Manufacturing: ISO 9001:2015 & cGMP-audited facility
• Intended Use: In-vitro laboratory research only

Storage & Handling

• Prior to reconstitution: store ≤ 8 °C in a dry environment
• After reconstitution: refrigerate 2 – 8 °C and use within 30 days
• Long-term preservation: aliquot and freeze at −20 °C
• Avoid repeated freeze–thaw cycles

Compliance Notice

Supplied exclusively to qualified professionals for controlled laboratory
applications. No dosage or administration guidance is provided. Buyer assumes
responsibility for safe handling and regulatory adherence.